The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Stem Cells in the Treatment of Refractory Chronic Migraines
Open accessAbstract
Background: Autologous adipose-derived stromal vascular fraction (SVF), which is rich in mesenchymal stromal cells, has been reported to be effective for the treatment of trigeminal neuropathic pain and chronic migraine and tension-type headaches. It is possible that stem cell activity targets neurogenic inflammation, which is a well-documented aspect of migraine pathogenesis. Methods: Adult patients with severe migraine-related disability as measured by the Migraine Disability Assessment (MIDAS) score who failed botulinum toxin injections and at least 3 prophylactic drugs were included in this study. The primary outcome measure was the change in MIDAS score 3 months after treatment. Standard liposuction was performed to obtain adipose tissue, from which SVF was isolated by centrifugation. A sample of each patient’s SVF was tested for the number of nucleated cells and their viability. Between 8 and 10 mL of SVF with 2.5–8.6 million viable cells were injected into the pericranial, neck, and trapezius muscles. Results: One man and 8 women were enrolled in the study. The mean age was 48 years, the mean duration of headaches was 16 years, the mean number of prophylactic drugs tried was 10, and the mean MIDAS score at baseline was 122. Three months after the procedure the mean MIDAS score was 88. Seven out of 9 patients had a decrease in their MIDAS score, but only 2 had meaningful improvement. Conclusion: The use of autologous adipose-derived SVF may be effective in the treatment of chronic refractory migraines. It is possible that the use of allogenic stem cells could offer a more practical and more effective approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., Laine, G. A., & Cox, C. S. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0253 · Cited by 1,292
Ra, J. C., Shin, I. S., Kim, S. H., Kang, S. K., Kang, B. C., Lee, H. Y., Kim, Y. J., Jo, J. Y., Yoon, E. J., Choi, H. J., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0466 · Cited by 580
Decreased number and function of endothelial progenitor cells in patients with migraine
Lee, S. T., Chu, K., Jung, K. H., Kim, D. H., Kim, E. H., Choe, V. N., Kim, J. H., Im, W. S., Kang, L., Park, J. E., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000294329.93565.94 · Cited by 200
Martelletti, P., Katsarava, Z., Lampl, C., Magis, D., Bendtsen, L., Negro, A., Russell, M. B., Mitsikostas, D. D., & Jensen, R. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-47 · Cited by 124
Refractory migraine in a headache clinic population
Irimia, P., Palma, J., Fernández‐Torrón, R., & Martínez‐Vila, E. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-94 · Cited by 102
Talwadekar, M., Kale, V. P., & Limaye, L. S. (2015) · Scientific Reports · doi:10.1038/srep15784 · Cited by 96
A preliminary report on stem cell therapy for neuropathic pain in humans
Vickers, R., Karsten, E., Lilischkis, R., & Flood, J. (2014) · Journal of Pain Research · doi:10.2147/jpr.s63361 · Cited by 90
Xue, S., Zhang, H., Zhang, P., Luo, J. D., Chen, Z., Jang, X.-D., & Xu, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.035 · Cited by 53
Migraine and tension-type headache treated with stromal vascular fraction: a case series
Bright, M. R., Bright, M. R., Bright, P., Hayne, S., & Thomas, W. D. (2014) · Journal of Medical Case Reports · doi:10.1186/1752-1947-8-237 · Cited by 19
Cited by
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Stem cell-based therapy for human diseases
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01134-4 · Cited by 1,074
Spinal cord injury: molecular mechanisms and therapeutic interventions
Hu, X., Xu, W., Ren, Y., Wang, Z., He, X., Huang, R., Ma, B., Zhao, J., Zhu, R., & Cheng, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01477-6 · Cited by 770
Weiss, A. R. R., & Dahlke, M. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01191 · Cited by 695
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders
Riazifar, M., Mohammadi, M. R., Pone, E. J., Yeri, A., Lässer, C., Segaliny, A. I., McIntyre, L. L., Shelke, G. V., Hutchins, E., Hamamoto, A., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01004 · Cited by 551
Lee, W.-S., Kim, H. J., Kim, K.-I., Kim, G. B., & Jin, W. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0122 · Cited by 497
Leyane, T. S., Jere, S. W., & Houreld, N. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137273 · Cited by 469
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 460
Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
Wang, B., Yao, K., Huuskes, B. M., Shen, H.-H., Zhuang, J., Godson, C., Brennan, E. P., Wilkinson-Berka, J. L., Wise, A. F., & Ricardo, S. D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.90 · Cited by 379
Mao, A. S., Shin, J.-W., Utech, S., Wang, H., Uzun, O., Li, W., Cooper, M., Hu, Y., Zhang, L., Weitz, D. A., et al. (2017) · Nature Materials · doi:10.1038/nmat4781 · Cited by 371
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 367
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., Veronesi, E., Horwitz, E. M., & Dominici, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0044 · Cited by 350
Xia, L., Zhang, C., Lv, N., Liang, Z., Ma, T., Cheng, H., Xia, Y., & Shi, L. (2022) · Theranostics · doi:10.7150/thno.69533 · Cited by 345
Alzheimer’s disease, dementia, and stem cell therapy
Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 338
Zheng, B., von See, M. P., Yu, E., Gunel, B., Lu, K., Vazin, T., Schaffer, D. V., Goodwill, P. W., & Conolly, S. M. (2016) · Theranostics · doi:10.7150/thno.13728 · Cited by 322
The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
Zhang, J., Huang, X., Wang, H., Liu, X., Zhang, T., Wang, Y., & Hu, D. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0240-9 · Cited by 310
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
Caplan, H., Olson, S. D., Kumar, A., George, M., Prabhakara, K. S., Wenzel, P., Bedi, S., Toledano-Furman, N. E., Triolo, F., Kamhieh-Milz, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01645 · Cited by 306
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Adelborg, K., Szépligeti, S. K., Holland-Bill, L., Ehrenstein, V., Horváth-Puhó, E., Henderson, V. W., & Sørensen, H. T. (2018) · BMJ · doi:10.1136/bmj.k96 · Cited by 301
Advancing application of mesenchymal stem cell-based bone tissue regeneration
Shang, F., Yu, Y., Liu, S., Ming, L., Zhang, Y., Zhou, Z., Zhao, J., & Jin, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.014 · Cited by 280
Sacco, S., Braschinsky, M., Ducros, A., Lampl, C., Little, P., van den Brink, A. M., Pozo-Rosich, P., Reuter, U., de la Torre, E. R., Sanchez Del Rio, M., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01130-5 · Cited by 266
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021) · Cell Proliferation · doi:10.1111/cpr.12956 · Cited by 265
Adult Stem Cells for Bone Regeneration and Repair
Iaquinta, M. R., Mazzoni, E., Bononi, I., Rotondo, J. C., Mazziotta, C., Montesi, M., Sprio, S., Tampieri, A., Tognon, M., & Martini, F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00268 · Cited by 259
Wu, M., Zhang, R., Zou, Q., Chen, Y., Zhou, M., Li, X., Ran, R., & Chen, Q. (2018) · Scientific Reports · doi:10.1038/s41598-018-23396-1 · Cited by 206
Neural stem cell therapy for subacute and chronic ischemic stroke
Boese, A. C., Le, Q.-S. E., Pham, D., Hamblin, M. H., & Lee, J.-P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0913-2 · Cited by 205
Xia, Y., Zhu, J., Yang, R., Wang, H., Li, Y., & Fu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1141601 · Cited by 87
Duma, C., Kopyov, O., Kopyov, A., Berman, M., Lander, E., Elam, M., Arata, M., Weiland, D., Cannell, R., Caraway, C., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04983-5 · Cited by 85
Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress
Laing, A. G., Fanelli, G., Ramirez-Valdez, A., Lechler, R. I., Lombardi, G., & Sharpe, P. T. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213170 · Cited by 59
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03352-1 · Cited by 56
Prakash, N., Kim, J., Jeon, J., Kim, S., Arai, Y., Bello, A. B., Park, H., & Lee, S.-H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00371-0 · Cited by 56
Lin, D., Chen, H., Xiong, J., Zhang, J., Hu, Z., Gao, J., Gao, B., Zhang, S., Chen, J., Cao, H., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05303-9 · Cited by 44
Yadav, P., Vats, R., Bano, A., & Bhardwaj, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118588 · Cited by 36
Sun, S., Xiao, J., Huo, J., Geng, Z., Ma, K., Sun, X., & Fu, X. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0758-0 · Cited by 36
Clavreul, A., Pourbaghi-Masouleh, M., Roger, E., Lautram, N., Montero-Menei, C. N., & Menei, P. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0605-2 · Cited by 35
Vargas-Rodríguez, P., Cuenca-Martagón, A., Castillo-González, J., Serrano-Martínez, I., Luque, R. M., Delgado, M., & González-Rey, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814117 · Cited by 25
Bahrambeigi, V., Ahmadi, N., Moisyadi, S., Urschitz, J., Salehi, R., & Haghjooy Javanmard, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-255 · Cited by 21
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis
Schwenk, E. S., Torjman, M. C., Moaddel, R., Lovett, J., Katz, D., Denk, W., Lauritsen, C., Silberstein, S. D., & Wainer, I. W. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1920 · Cited by 20
Shrestha, K. R., Jeon, S. H., Jung, A. R., Kim, I. G., Kim, G. E., Park, Y. H., Kim, S. H., & Lee, J. Y. (2019) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-019-00187-x · Cited by 14
Maternal Lifestyle During Pregnancy and Its Influence on Offspring’s Telomere Length
Vakonaki, E., Vitiadou, M. T., Panteris, E., Tzatzarakis, M., Tsatsakis, A., & Hatzidaki, E. (2025) · Life · doi:10.3390/life15081250 · Cited by 6
Metadata
- Authors
- Mauskop, A., & Rothaus, K. O.
- Venue
- Case Reports in Neurology
- Publisher
- S. Karger AG
- Published
- 2017-06-14
- Volume
- 9
- Issue
- 2
- Pages
- 149-155
- ISSN
- 1662-680X (ISSN-L)
- OpenAlex
- W2638561866
- Cited by
- 793
- References
- 9
- FWCI
- 56.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.